The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Immunocytochemistry reveals RANKL expression of myeloma cells
Open accessAbstract
Two highly interesting papers related to osteoclastic activation in multiple myeloma were published in the December 15 issue of Blood. [1][1],[2][2] These studies were related to the imbalance of 2 molecules involved in the regulation of bone resorption: receptor activator of NF-kappaB ligand (RANKL
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Pearse, R. N., Sordillo, E. M., Yaccoby, S., Wong, B. R., Liau, D. F., Colman, N., Michaeli, J., Epstein, J., & Choi, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201394498 · Cited by 518
Giuliani, N., Bataille, R., Mancini, C., Lazzaretti, M., & Barillé, S. (2001) · Blood · doi:10.1182/blood.v98.13.3527 · Cited by 415
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
Croucher, P. I. (2001) · Blood · doi:10.1182/blood.v98.13.3534 · Cited by 376
Turner, N. A., Moake, J. L., & McIntire, L. V. (2001) · Blood · doi:10.1182/blood.v98.12.3340 · Cited by 146
Human bone marrow myeloma cells express RANKL.
Sezer, O., Heider, U., Jakob, C., Eucker, J., Possinger, K., & Roodman, G. D. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.1.353 · Cited by 104
Self-citationSezer, O., Heider, U., Zavrski, I., & Possinger, K. (2001) · PubMed · Cited by 47
Self-citationShi, S., Tandon, A. K., Haussmann, R. R. M., Kalra, K. L., & Taylor, C. R. (1993) · Acta Oto-Laryngologica · doi:10.3109/00016489309135766 · Cited by 29
Research works printed but not linked: 1
- Altamirano, 2000, RANKL is expressed in malignant multiple myeloma cell lines [abstract]., Blood., 96, 365a
Cited by
Sorted by citations
Items 101–110 of 110
Rola RANK/RANKL i OPG w szpiczaku plazmocytowym* The role of RANK/RANKL and OPG in multiple myeloma
Kandefer‐Szerszeń, M. (2006)
Grogan, T. M., Gelbspan, D., & Rimsza, L. M. (2004) · CRC Press eBooks · doi:10.1201/b13347-12
Drake, M. T. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8520-9_17
Impact of MGUS and myeloma on skeletal health
Roodman, G. D., & Drake, M. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00058-7
Review The role of the bone marrow microenvironment in multiple myeloma
Vanderkerken, K. (2005)
Biological relationship between bone and myeloma cells
Edwards, C. M., & Lawson, M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00047-5
Hesslein, D. G. T., Aguila, H. L., & Horowitz, M. C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375670-1.10003-2 · Cited by 1
Li, T., Qiu, D., Chen, Q., Yang, A., Chen, J., & Zeng, Z. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4149831
Heider, U., Zavrski, I., Jakob, C., Fleissner, C., & Sezer, O. (2004) · Cancer Research · doi:10.1158/0008-5472.773.64.2
Self-citationYee, A. J., Hideshima, T., Raje, N. S., & Anderson, K. C. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm122.pub2
Metadata
- Authors
- Sezer, O., Heider, U., Jakob, C., Zavrski, I., Eucker, J., Possinger, K., Sers, C., & Krenn, V.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Sezer, Orhan
- Heider, Ulrike
- Jakob, Christian
- Zavrski, Ivana
- Eucker, Jan
- Possinger, Kurt
- Sers, Christine
- Krenn, Veit
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2002-06-15
- Volume
- 99
- Issue
- 12
- Pages
- 4646-4647
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2020103166
- Cited by
- 110
- References
- 7
- Citations by year
- 2022: 5 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 5 · 2015: 2 · 2014: 3 · 2013: 3 · 2012: 3
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- RANKL, multiple myeloma, myeloma cells, osteoclast activation, bone resorption, osteolytic lesions, NF-κB signaling
- MeSH terms
- Bone Marrow Cells, Carrier Proteins, Flow Cytometry, Humans, Immunohistochemistry, Membrane Glycoproteins, Multiple Myeloma, Neoplasm Proteins, Osteolysis, Plasma Cells, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
